Dr. Joel Claveau, Medical Oncologist, will review the latest news, clinical data and other updates as they relate to melanoma treatment in the adjuvant setting, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting that took place in June 2018 in Chicago, Illinois and the European Society of Medical Oncology (ESMO) in Munich, Germany, October 2018. Dr. Claveau will share his key insights into what the landscape of adjuvant melanoma immuno-oncology treatment looks like for the near future in Canada. Additionally, Dr. Adrian Gunaratne, Medical Science Liaison with Novartis, will detail the science behind targeted therapy and what is coming for Canadian melanoma patients in the adjuvant setting with a BRAF positive mutation.
Facilitated by Kathy Barnard of Save Your Skin Foundation, the discussion will continue with a patient and a caregiver both having had treatment access challenges in the adjuvant melanoma setting, and how their experience impacts their lives and that of their families.
Click the link below to register for this free webinar: